Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology

What Doctor Treats Progressive Supranuclear Palsy (PSP)?

At a Glance

To ensure an accurate diagnosis and treatment plan for Progressive Supranuclear Palsy (PSP), patients should see a fellowship-trained Movement Disorder Specialist. These experts can distinguish PSP from Parkinson's disease and will coordinate a multidisciplinary care team.

Being told you might have Progressive Supranuclear Palsy (PSP) after initially receiving a Parkinson’s disease diagnosis can be a frustrating, confusing, and frightening experience. Because PSP is a rare condition that shares many early symptoms with Parkinson’s, it is critical to seek care from a fellowship-trained Movement Disorder Specialist rather than a general neurologist. A Movement Disorder Specialist has completed additional years of specialized training and is far more likely to recognize the subtle nuances of PSP, differentiate it from other conditions, and connect you with the multidisciplinary care team you need to manage your symptoms proactively.

Why a Specialist is Essential for PSP

Early in the disease process, PSP can be incredibly difficult to distinguish from Parkinson’s disease [1][2]. However, obtaining an accurate diagnosis is important because PSP requires a different management approach. Here is why specialized expertise matters:

  • Spotting the Red Flags: Unlike typical Parkinson’s disease, PSP usually does not respond well to standard anti-parkinsonian medications like levodopa [1][3]. While some patients (particularly those with the PSP-Parkinsonism subtype) may experience a mild, temporary benefit, a specialist will recognize the overall lack of response as a major clue.
  • Recognizing Unique Symptoms: Specialists are trained to identify the hallmark physical signs of PSP. These include early and frequent backward falls, a “surprised” or furrowed facial expression known as the Procerus sign, and difficulty moving the eyes up or down (vertical supranuclear gaze palsy) [4][5]. If you have been struggling to read a book, walk down stairs safely, or look down at your plate while eating, this vertical eye movement issue is the clinical reason why.
  • Applying Modern Diagnostic Criteria: A true expert will use the most up-to-date guidelines, such as the Movement Disorder Society (MDS) clinical diagnostic criteria, which helps them identify the different variations of PSP [6][7].
  • Advanced Brain Imaging: Specialists know exactly what to look for on an MRI. They look for highly specific structural changes in the brain, such as midbrain atrophy (shrinkage in a specific part of the brainstem). This shrinkage often creates a shape on the MRI scan known as the “Hummingbird sign” or “Morning Glory sign,” which helps confidently tell PSP apart from other parkinsonian disorders [8][9].

How to Find and Vet a Neurologist’s Experience

When you have a rare disease, finding the right doctor is the first step in strong self-advocacy. You can start your search by looking for “Centers of Excellence” through patient advocacy organizations like CurePSP or by using the provider directory from the International Parkinson and Movement Disorder Society.

Once you find a specialist, it is entirely reasonable to interview them to ensure they have the right background. Here are practical ways to gauge a doctor’s expertise:

Ask About Their Patient Panel

A general neurologist may only see one or two PSP cases in their entire career. In contrast, a Movement Disorder Specialist at a large academic medical center may actively follow dozens of patients. Ask them directly how many patients with PSP they currently manage.

Ask About Symptom Tracking

Experienced specialists use specific, validated tools to monitor your disease over time. Ask if they use the Progressive Supranuclear Palsy Rating Scale (PSPRS) or the PSP-Clinical Deficits Scale (PSP-CDS) [10][11]. These scales allow the doctor to objectively measure disease severity and track your progression at each visit.

Evaluate Their Team Approach

PSP is a complex disease that affects many different aspects of your health, including mobility, swallowing, sleep, and mood [12][13]. For example, swallowing difficulties (dysphagia) are very common and require careful management to prevent complications like aspiration pneumonia [14].

An expert specialist will not work alone; they will act as the “quarterback” for a multidisciplinary team. They should encourage starting physical, occupational, and speech therapy right away so you can proactively build strength and strategies, rather than waiting for a crisis. Additionally, they should seamlessly integrate neuro-palliative care into your plan early on, which is a standard of care for complex symptom management and ensuring your quality of life remains the top priority.

Common questions in this guide

What type of doctor should I see for Progressive Supranuclear Palsy?
You should see a fellowship-trained Movement Disorder Specialist. Because PSP is rare and shares early symptoms with Parkinson's disease, a general neurologist may not have the specific experience needed to recognize its unique signs and appropriately manage the condition.
Why do doctors often misdiagnose PSP as Parkinson's disease initially?
Early in the disease, PSP looks very similar to Parkinson's disease, making it difficult to distinguish. However, a key difference that specialists look for is that PSP symptoms typically do not improve when taking standard Parkinson's medications like levodopa.
What specific signs will a specialist look for to diagnose PSP?
A specialist will check for hallmark signs such as frequent backward falls, a furrowed facial expression, and difficulty moving your eyes up and down. They will also review an MRI for specific structural changes in the midbrain, known as the Hummingbird sign.
How can I tell if a neurologist is experienced in treating PSP?
You can ask the doctor directly how many PSP patients they currently treat and if they use specific tracking tools like the Progressive Supranuclear Palsy Rating Scale. It is also helpful to seek out doctors at academic medical centers or patient advocacy Centers of Excellence.
What other healthcare professionals should be on my PSP care team?
Your specialist should act as the coordinator for a multidisciplinary care team. This team should include physical, occupational, and speech therapists to build strength, as well as neuro-palliative care providers to help manage complex symptoms.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are you a fellowship-trained Movement Disorder Specialist, and approximately how many patients with Progressive Supranuclear Palsy do you currently manage?
  2. 2.Do you use specific tracking tools like the PSP Rating Scale (PSPRS) to monitor my condition over time?
  3. 3.Since my symptoms haven't responded well to levodopa, how will we adjust my treatment plan moving forward?
  4. 4.Can you refer me to physical, occupational, and speech therapists who have experience with PSP so I can start proactive therapy right away?
  5. 5.How do you integrate neuro-palliative care into your treatment approach to help manage complex symptoms and prioritize my quality of life?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Tau in Atypical Parkinsonisms: A Meta-Analysis of in Vivo PET Imaging Findings.

    Mena AM, Chen R, Graff-Guerrero A, et al.

    Movement disorders clinical practice 2023; (10(12)):1725-1737 doi:10.1002/mdc3.13885.

    PMID: 38094644
  2. 2

    Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.

    Quattrone A, Bianco MG, Antonini A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(6)):1272-1281 doi:10.1002/mds.28992.

    PMID: 35403258
  3. 3

    Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.

    Quattrone A, Morelli M, Vescio B, et al.

    Movement disorders : official journal of the Movement Disorder Society 2019; (34(4)):487-495 doi:10.1002/mds.27621.

    PMID: 30759325
  4. 4

    Interventions in progressive supranuclear palsy.

    Koros C, Stamelou M

    Parkinsonism & related disorders 2016; (22 Suppl 1()):S93-5.

    PMID: 26459661
  5. 5

    Procerus Sign: Mechanism, Clinical Usefulness, and Controversies.

    Bhattacharjee S

    Annals of Indian Academy of Neurology 2018; (21(2)):164-165 doi:10.4103/aian.AIAN_408_17.

    PMID: 30122846
  6. 6

    Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules.

    Ogawa T, Hatano T, Oyama G, et al.

    Movement disorders clinical practice 2020; (7(2)):240-242 doi:10.1002/mdc3.12894.

    PMID: 32071951
  7. 7

    Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome.

    Parmera JB, de Godoi Carneiro C, de Almeida IJ, et al.

    Movement disorders clinical practice 2024; (11(3)):238-247 doi:10.1002/mdc3.13959.

    PMID: 38155526
  8. 8

    In search of the optimal MRI marker for progressive supranuclear palsy: a large, single-center, retrospective study on the effect of phenotype, diagnostic certainty and disease duration.

    Constantinides VC, Giagkou N, Brinia ME, et al.

    Journal of neurology 2025; (272(8)):523 doi:10.1007/s00415-025-13262-2.

    PMID: 40690031
  9. 9

    Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy.

    Owens E, Krecke K, Ahlskog JE, et al.

    Parkinsonism & related disorders 2016; (28()):107-11.

    PMID: 27160570
  10. 10

    A 15-Item modification of the PSP rating scale to improve clinical meaningfulness and statistical performance.

    Dam T, Yang L, Gillis C, et al.

    Nature communications 2025; (16(1)):414 doi:10.1038/s41467-024-55442-0.

    PMID: 39762226
  11. 11

    A Modified Progressive Supranuclear Palsy Rating Scale.

    Grötsch MT, Respondek G, Colosimo C, et al.

    Movement disorders : official journal of the Movement Disorder Society 2021; (36(5)):1203-1215 doi:10.1002/mds.28470.

    PMID: 33513292
  12. 12

    The Non-Motor Symptom Profile of Progressive Supranuclear Palsy.

    Chaithra SP, Prasad S, Holla VV, et al.

    Journal of movement disorders 2020; (13(2)):118-126 doi:10.14802/jmd.19066.

    PMID: 32241079
  13. 13

    Depression and Apathy across Different Variants of Progressive Supranuclear Palsy.

    Bower SM, Weigand SD, Ali F, et al.

    Movement disorders clinical practice 2022; (9(2)):212-217 doi:10.1002/mdc3.13396.

    PMID: 35146060
  14. 14

    Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy.

    Clark HM, Tosakulwong N, Weigand SD, et al.

    Movement disorders : official journal of the Movement Disorder Society 2021; (36(11)):2669-2675 doi:10.1002/mds.28731.

    PMID: 34426998

This page is for educational purposes to help you navigate your healthcare journey. It does not replace professional medical advice, diagnosis, or treatment from a qualified movement disorder specialist.

Get notified when new evidence is published on Progressive supranuclear palsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.